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ABSTRACT
Objective: Loratadine (LOR) is a biopharmaceutics classification system Class II drug that has low solubility and high permeability, so its absorption 
rate is determined by the dissolution rate. The aim of this study was to prepare an LOR-fumaric acid (LOR-FUM) binary mixture and to investigate its 
influence on the solubility and dissolution rate of LOR.
Methods: LOR-FUM binary mixture was prepared by the wet grinding method in an equimolar ratio by the addition of two drops of methanol. 
Characterization of LOR-FUM binary mixture was conducted by the construction of the phase solubility, powder X-ray diffractometry, Fourier 
transforms infrared spectroscopy, and polarizing microscopy methods. Solubility test was performed in water at room temperature, whereas the 
in vitro dissolution test was performed in the pH 1.2, 4.5, and 6.8 buffer solutions.
Results: The phase solubility curve of LOR in FUM solution is similar to type BS. The powder X-ray diffraction results show the crystallinity of LOR was 
changed become more amorphous indicating the salt formation. Fourier transforms infrared spectroscopy (FTIR) spectra of LOR-FUM binary mixture 
showed the vibration peaks of an imine group on the pyridine ring of LOR and carbonyl group on the FUM are not detected. On the other hand, the 
polarizing microscope images showed the crystal habit of LOR-FUM binary mixture after recrystallized from methanol contrast to crystal habit of 
its pure components. The solubility in water of LOR-FUM binary mixture was higher than pure LOR. Amount of LOR released from LOR-FUM binary 
mixture in pH 4.5 and 6.8 buffer solutions was faster than from pure LOR.
Conclusion: A binary mixture of LOR and FUM may improve the solubility and dissolution rate of LOR.
Keywords: Loratadine, Fumaric acid, Binary mixture, Solubility, Dissolution rate.
INTRODUCTION
Loratadine (LOR) is a second generation antihistamine used to treat 
allergies without causing drowsiness. The activity mechanism of LOR is 
a competitive-reversible inhibitor of the histamine receptor tissue, and 
therefore, this prevents histamine binding and receptor activation [1]. 
LOR is a drug belonging to a Class II in the biopharmaceutics 
classification system (BCS), which it has low solubility in water and high 
permeability [2]. Moreover, LOR is a weak base with a pKa of 5.0 and its 
solubility is affected by pH media [3]. Accordingly, LOR has the lowest 
solubility at pH 7.5 and the highest at pH 1.2 [2]. It is known that a drug 
with either poor solubility in water or low permeability often causes 
low bioavailability. The efforts to increase the solubility of LOR have 
previously been reported, among others, solid dispersion [4,5] and the 
formation of inclusion complex [6-8].
Modification of solid forms of drugs through the formation of salts or co-
crystals is a very good technique to increase the solubility of some drugs 
[9-11]. Co-crystal is a new solid form consists of a single crystalline 
phase of several components in a certain stoichiometric ratio, where 
different types of molecules that interact with hydrogen bonds or other 
noncovalent bonds [12]. The pyridine ring in their chemical structure 
LOR as shown in Fig. 1a allows the proton transfer with carboxylic acids 
to form a salt. Furthermore, N of the pyridine ring may also act as a 
hydrogen bond acceptor, allowing the formation of co-crystal when it 
binds to the hydroxyl group of carboxylic acids. Fumaric acid (FUM) is 
a dicarboxylic acid that is safe to use orally, and it’s widely employed as 
an excipient in salt or co-crystal formation. FUM (Fig. 1b) can improve 
the solubility of several drugs through the formation of salt [13,14] and 
co-crystals [15-18]. Provision of mechanical energy such as grinding in 
a solid binary mixture with or without the addition of solvents can lead 
to interactions, among others, an eutectic mixture, salt, or co-crystal 
formation. The purpose of this research was mainly to prepare a binary 
mixture of LOR-FUM and to investigate its effect on the solubility and 
dissolution rate of LOR.
MATERIALS AND METHODS
Materials
LOR was obtained from Dr. Reddy”s, India. FUM was purchased from 
Sigma-Aldrich, Singapore (>99%). All reagents and solvents were 
purchased from Merck, Indonesia, without any further purification.
Phase solubility test of LOR in FUM solution
Approximately, 50 mg of LOR put into each vial containing numerous 
concentrations of FUM solution in water (15-50 mM) and shaken 
on an orbital shaker at room temperature. The samples in the vials 
were filtered after 24 hrs, and then, the clear filtrate was analyzed by 
ultraviolet (UV) spectrophotometry method at a wavelength of 283 nm. 
The phase solubility curve was constructed by plotting the solubility of 
LOR to the various concentrations of FUM.
Preparation of LOR-FUM binary mixture by wet grinding method
A binary mixture of LOR-FUM was prepared by milling an equimolar 
ratio of LOR-FUM physical mixture in the mortar using a pestle with the 
addition of two drops of methanol for five minutes. The grinding result 
was dried and ready to be characterized.
Characterization by powder X-ray diffraction method
The amount of 200 mg each sample (LOR-FUM binary mixture, LOR, 
and FUM) was placed in a glass container, the sample surface was 
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flattened, and then the X-ray powder diffraction pattern was observed 
using a Philips PW-1710 X-ray diffraction system over a range of angles 
2θ=5-35°, the speed of 2°/minutes, a voltage of 40 kV, and a current of 
30 mA. Then, the powder X-ray diffraction pattern of LOR-FUM binary 
mixture was compared with the diffraction pattern of pure LOR and FUM.
Characterization by fourier transforms infrared (FTIR) 
spectroscopy method
Each sample was homogeneously mixed with potassium bromide 
(KBr) at a weight ratio of 1:5 and conducted by Shimadzu Affinity-1 
FTIR spectrophotometer. The KBr powder is used as a blank for 
background correction in FTIR, and the samples were scanned in the 
range of 4000-400/cm. The FTIR spectra of LOR-FUM binary mixture 
was compared with the FTIR spectra of pure LOR and FUM.
The characterization of LOR-FUM crystal habit by polarizing 
microscope
As much as 2 mg of LOR-FUM physical mixture was placed on the 
glass slide, added two drops of methanol, covered with a glass lid, and 
allowed to recrystallized. The crystal habit after recrystallization was 
observed using an Olympus BX-53 polarizing microscope equipped 
with an Optilab Advanced Plus camera and compared with crystal habit 
of its pure components after recrystallized from the same solvent.
Solubility test
Solubility test was conducted on the binary mixture of the LOR-FUM and 
pure LOR in water at room temperature. A certain number of samples 
were inserted into the vial containing 10 mL of water and shaken on an 
orbital shaker. After 24 hrs, the sample was filtered and then the filtrate 
of the sample was diluted and analyzed by a UV spectrophotometer at 
a wavelength of 283 nm.
In vitro dissolution test
The in vitro dissolution test was carried out on the LOR-FUM binary 
mixture and pure LOR in 900 mL of pH 1.2, 4.5, and 6.8 buffer solutions 
at 37±0.5°C using a Type II apparatus with 50 rotations/minutes 
(rpm) of speed for 120 minutes. A 10 mL of sample was taken after 
5, 10, 15, 30, 60, 90, and 120 minutes and replaced with the same 




The formation of the salt or co-crystal can be predicted by knowing the 
type of phase solubility curve. According to Higuchi and Connors, phase 
solubility curve is a curve that describes the solubility of a substance in 
the solution at various concentrations of other substances consisting AL, 
AP, AN, BS, and BL types [19]. The phase solubility curve of LOR in various 
concentrations of FUM solution is presented in Fig. 2. The solubility of 
LOR at 15, 20, 30, 35, 45, and 50 mM concentrations of FUM solutions 
were 2.3, 3.0, 14.6, 15.0, 6.9, and1.9 µM, respectively, and therefore, the 
type of phase solubility curve is BS. In this type, the solubility of LOR 
increased sharply in concentrations range of 15-30 mM of FUM solution 
due to the formation of dissolved new solid form (salt or co-crystal). At 
concentrations of 30-35  mM, the saturation condition began to occur as 
a result reaching solubility product constant (Ksp) of LOR-FUM salt or co-
crystal. Consequently, the solubility of LOR in the concentration range was 
fixed. Conversely, the increasing of FUM concentration up to 50 mM caused 
a decline in FUM solubility, therefore, the precipitated of salt or co-crystal 
were formed. These results express that between LOR and FUM occurred 
an interaction. There are two possibilities of the interaction, the first is the 
transfer of a proton from FUM to LOR to create the salt, and the second is 
the formation of hydrogen bonds between the LOR and FUM to assemble 
the co-crystal.
Preparation of LOR-FUM binary mixture
The grinding of a physical mixture of two solid substances either with 
or without the addition of solvent can lead to the formation of salt [20] 
or co-crystal [21]. In this study, the grinding was conducted on the 
equimolar of LOR-FUM physical mixture with the addition of a few 
drops of methanol, and this grinding technique is known as wet grinding 
or solvent-drop grinding method [22]. The purpose of the addition of 
methanol was to accelerate the two components interaction, as a result 
of the rapid achievement of the amorphous state which causes each 
component to be more reactive [23]. Besides increasing the interaction, 
methanol was also able to dissolve of LOR and FUM. At the beginning 
of the wet grinding, a sticky mixture was created that indicates the 
amorphous state formation, followed by the recrystallization process 
into a dry solid form.
Characterization by powder X-ray diffraction method
The powder X-ray diffractometry is a very powerful method to 
analyze the formation of a new crystalline phase [24]. The powder 
X-ray diffraction pattern of LOR, FUM, and LOR-FUM binary mixture 
are shown in Fig. 3. The powder X-ray diffraction pattern of LOR raw 
material shows main peaks at 6.4, 12.7, 15.1, 19.6, 21.2, 23.8, and 
30.5° of 2θ angle, and this diffraction pattern is consistent with the 
crystal structure of LOR with BEQGIN reference code [25]. The FUM 
raw material has main peaks of powder X-ray diffraction at 18.6, 
22.8, 24.5, 25.9, 28.9, and 29.5° 2θ angle, and the diffraction pattern 
conform to form α of FUM with FUMAAC reference code [26]. The initial 
characterization of the formation of new solid form was conducted by 
comparing the powder X-ray diffraction pattern of a binary mixture 
of LOR-FUM with its parent components. The difference between 
powder X-ray diffraction pattern of binary mixture and powder X-ray 
diffraction pattern of each component indicates the formation of co-
crystal [27]. The powder X-ray diffraction pattern of a binary mixture 
between LOR and FUM in Fig. 2 was not different from the powder X-ray 
diffraction pattern of pure LOR and FUM. The main peaks of LOR and 
FUM still appear in the diffraction pattern of LOR-FUM binary mixture. 
Nevertheless, the powder X-ray diffraction pattern of LOR-FUM binary 
mixture showed the changes become more amorphous, which is 
denoted by lowering the intensity of the main peaks. Decreasing the 
intensity peaks is one of the characteristics of salt formation, and 
therefore, it is suspected to occur due to the formation of LOR-FUM salt.
Characterization by FTIR method
IR can also be employed to investigate the interaction between two 
or more components. Accordingly, it is capable of characterizing the 
Fig. 1: Chemical structures of (a) loratadine and (b) fumaric acid
Fig. 2: Phase solubility curve of loratadine in various 
concentrations of fumaric acid solution in water
a b
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formation of co-crystals, salts, polymorphs, hydrates, and solvates [28]. 
The co-crystal exists due to the existence of the hydrogen bonds, 
whereas the salt occurs due to the occurrence of proton transfer and 
acceptance between two interacted substances. In Fig. 4., LOR has 
a characteristic absorption band at 1705 cm−1 due to the stretching 
vibration of carbonyl (C=O) group in the ester and 1643 cm−1 due to 
stretching vibration of imine group (C=N) in the pyridine ring. FUM 
has a wide band in the region 3500-3000 cm−1 caused by stretching 
vibration -OH group and 1678 cm−1 due to the stretching vibration of 
the carbonyl group. FTIR spectra of LOR-FUM binary mixture showed 
the vibration peaks of an imine group in the pyridine ring of LOR 
and carbonyl group in the FUM are not detected. Accordingly, the 
undetected of peaks in these groups may be due to the occurrence of 
proton transfer from the carboxylic group of FUM to the imine group of 
the pyridine ring of LOR to form a salt.
The characterization of LOR-FUM crystal habit by polarizing 
microscope
The polarizing microscopy method is able to indicate the formation a 
new solid form through changes in the crystal habit [29]. The polarizing 
microscope is capable of exhibiting the difference in the crystal habit 
between LOR-FUM binary mixture and its pure components after 
recrystallized from methanol. Fig. 5 shows that the LOR has anhedral-
shaped crystal habit, whereas FUM has dendritic-shaped crystal habit. 
However, the recrystallization of LOR-FUM binary mixture produced 
different habits from its pure components. This difference may be due 
to the formation of LOR-FUM salt.
Solubility test
The assay of LOR in a mixed solution of LOR and FUM from 
solubility and dissolution test results was carried out by direct UV 
spectrophotometry method. FUM has no absorption at the maximum 
absorption wavelength of LOR (λ=283 nm), so it does not interfere with 
the absorption of LOR. The influence of a binary mixture of LOR-FUM 
on the solubility of LOR can be determined by comparing the solubility 
of pure LOR and LOR-FUM binary mixture in water (neutral medium). 
The solubility of LOR from the LOR-FUM binary mixture in water at 
room temperature was 84-folds higher than pure LOR. The significant 
improvement of the LOR solubility from this binary mixture caused by 
increasing the amount of protonated N of the pyridine ring because of 
the existence of FUM.
In vitro dissolution test
The gastrointestinal absorption rate of BCS Class II drugs is limited by 
its dissolution rate, and consequently, the drugs in this class will be 
quickly absorbed when they have a rapid dissolution rate [5]. In vitro 
dissolution test was performed on pure LOR and LOR-FUM binary 
mixture in pH 1.2, 4.5, and 6.8 buffer solutions at 37°C to approach the 
real condition in the gastrointestinal tract [30]. The dissolution profiles 
Fig. 3: Powder X-ray diffraction pattern of loratadine (LOR), 
fumaric acid (FUM), and LOR-FUM binary mixture
Fig. 4: Fourier transforms infrared spectroscopy spectra of 
loratadine (LOR), fumaric acid (FUM), and LOR-FUM binary 
mixture
Fig. 5: Polarizing microscope photo of loratadine (LOR), fumaric 
acid (FUM), and LOR-FUM after recrystallized from methanol 
solvent
Fig. 6: The dissolution profile of pure loratadine (LOR) and 
LOR-fumaric acid binary mixture in pH 1.2, 4.5, and 6.8 buffer 
solutions
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of LOR from the LOR-FUM binary mixture and pure LOR in the all pH 
buffer solutions are shown in Fig. 6. Because of the solubility of LOR 
decrease by increasing of pH [3], the amount of LOR released both pure 
LOR and LOR-FUM binary mixture in pH 1.2 is faster than the others. 
The percentage of LOR dissolved from both samples after 5 minutes 
have reached more than 80% in pH 1.2; therefore, the difference of 
dissolution rate in between LOR-FUM binary mixture and pure LOR was 
not significant. On the contrary, the percentage of drug dissolved after 
5 minutes from LOR-FUM binary mixture in the pH 4.5 and 6.8 buffer 
solutions was higher than from pure LOR. In these pH, the amount of 
LOR ionized from LOR-FUM binary mixture was higher than pure LOR, 
and this may be related to the LOR-FUM salt formation.
CONCLUSION
A binary mixture of LOR-FUM had been prepared by the wet grinding 
method and characterized by construction of the phase solubility, 
powder X-ray diffraction, FTIR spectroscopy, and microscopy methods. 
The phase solubility curve of LOR in numerous concentrations of FUM 
solution is BS type, and consequenly, it is supposedly assembled a salt 
or a co-crystal between LOR and FUM. Although there is no difference 
in the powder X-ray diffraction pattern between the LOR-FUM binary 
mixture and its pure constituents, the intensity of this binary mixture 
is lower than its pure components. The characterization results show 
the differences in the FTIR spectra and crystal habit between the 
LOR-FUM binary mixture and their pure components. The LOR-FUM 
binary mixture may improve the solubility of LOR in water and the 
dissolution rate in pH 4.5 and 6.8 buffer solutions. The enhancement 
of the solubility and the dissolution rate of LOR may be due to the salt 
formation.
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